ArticleVaccines2022

A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines.

Louise Goksøyr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.